• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚雅加达肝硬化和肝细胞癌中的乙型肝炎病毒感染

Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.

作者信息

Sulaiman H A

机构信息

Department of Internal Medicine, University of Indonesia Faculty of Medicine, Jakarta.

出版信息

Gastroenterol Jpn. 1989 Aug;24(4):434-41. doi: 10.1007/BF02774353.

DOI:10.1007/BF02774353
PMID:2550307
Abstract

The relationship between hepatitis B virus (HBV) infection and 144 cases with liver cirrhosis (LC) and 82 cases with hepatocellular carcinoma (HCC), admitted to the Department of Internal Medicine, Dr. Cipto Mangunkusmo Hospital in Jakarta, was investigated within the period from January 1 until December 31, 1984. The prevalence of HBsAg in 144 cases with LC was 41.1%, anti-HBs 33.3% and anti-HBc alone 16.0%. In only 9.0% no markers were found. The prevalence of HBeAg in 60 cases HBsAg positive LC was 35.0%, anti-HBe was 41.7% and in 23.3% both markers were negative. Among 82 cases with HCC, the prevalence of HBsAg was 47.6%, anti-HBs was 25.6% and anti-HBc alone was 15.9%. The prevalence of HBeAg in 39 cases with HCC was 25.6%, anti-HBe was 51.3% and in 23.1% both markers were negative. Age distribution between HBsAg positive and negative in LC was observed significant difference (P less than 0.05). Mean age of HBsAg positive group in LC was 5 years younger than that of the HBsAg negative group.

摘要

1984年1月1日至12月31日期间,对雅加达西托·曼贡库斯莫医院内科收治的144例肝硬化(LC)患者和82例肝细胞癌(HCC)患者与乙型肝炎病毒(HBV)感染之间的关系进行了调查。144例LC患者中,HBsAg阳性率为41.1%,抗-HBs阳性率为33.3%,单纯抗-HBc阳性率为16.0%。仅9.0%未发现标志物。60例HBsAg阳性的LC患者中,HBeAg阳性率为35.0%,抗-HBe阳性率为41.7%,两种标志物均阴性的占23.3%。82例HCC患者中,HBsAg阳性率为47.6%,抗-HBs阳性率为25.6%,单纯抗-HBc阳性率为15.9%。39例HCC患者中,HBeAg阳性率为25.6%,抗-HBe阳性率为51.3%,两种标志物均阴性的占23.1%。观察到LC患者中HBsAg阳性和阴性的年龄分布存在显著差异(P小于0.05)。LC患者中HBsAg阳性组的平均年龄比HBsAg阴性组小5岁。

相似文献

1
Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.印度尼西亚雅加达肝硬化和肝细胞癌中的乙型肝炎病毒感染
Gastroenterol Jpn. 1989 Aug;24(4):434-41. doi: 10.1007/BF02774353.
2
The relationship of hepatocellular carcinoma and liver cirrhosis to hepatitis B virus infection in the Philippines.菲律宾肝细胞癌及肝硬化与乙型肝炎病毒感染的关系
Gastroenterol Jpn. 1989 Aug;24(4):425-33. doi: 10.1007/BF02774352.
3
[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].[抗-HBc及隐匿性乙型肝炎病毒感染在HBsAg和抗-HCV阴性酒精性肝硬化患者肝细胞癌发生中的意义]
Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67.
4
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.成人慢性乙型肝炎病毒感染的自然史,重点关注肝硬化和肝细胞癌的发生情况。
J Gastroenterol Hepatol. 2000 May;15 Suppl:E25-30. doi: 10.1046/j.1440-1746.2000.02097.x.
5
Hepatitis B virus profile of hepatocellular carcinoma in the Philippines.菲律宾肝细胞癌的乙肝病毒概况
Cancer. 1981 Oct 1;48(7):1590-5. doi: 10.1002/1097-0142(19811001)48:7<1590::aid-cncr2820480720>3.0.co;2-3.
6
High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.尼泊尔肝硬化或肝细胞癌患者中乙肝病毒感染及下腔静脉阻塞的高患病率。
J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8. doi: 10.1111/j.1440-1746.2006.04611.x.
7
Association of hepatitis B virus infection with hepatocellular carcinoma in American patients.美国患者中乙型肝炎病毒感染与肝细胞癌的关联。
Int J Cancer. 1980 Dec 15;26(6):711-5. doi: 10.1002/ijc.2910260603.
8
HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.HBeAg/抗-HBe系统与HBsAg阳性肝硬化患者原发性肝细胞癌的发生
Hepatogastroenterology. 1983 Feb;30(1):3-5.
9
High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.日本肝细胞癌患者中乙肝和丙肝病毒标志物的高流行率。
Gastroenterol Jpn. 1993 Aug;28(4):547-53. doi: 10.1007/BF02776954.
10
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.乙型肝炎病毒既往感染在日本HBs抗原阴性及抗-HCV阴性肝细胞癌患者中的作用:病因学及分子生物学研究
J Exp Clin Cancer Res. 1999 Sep;18(3):379-89.

引用本文的文献

1
Prevalence of Hepatocellular Carcinoma in Hepatitis B Population within Southeast Asia: A Systematic Review and Meta-Analysis of 39,050 Participants.东南亚乙肝人群中肝细胞癌的患病率:对39,050名参与者的系统评价和荟萃分析
Pathogens. 2023 Oct 6;12(10):1220. doi: 10.3390/pathogens12101220.
2
Hepatitis B virus infection in Indonesia.印度尼西亚的乙型肝炎病毒感染
World J Gastroenterol. 2015 Oct 14;21(38):10714-20. doi: 10.3748/wjg.v21.i38.10714.
3
The effect of propranolol in malay patients with liver cirrhosis - a pharmacodynamic evaluation.

本文引用的文献

1
HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.HBeAg/抗-HBe系统与HBsAg阳性肝硬化患者原发性肝细胞癌的发生
Hepatogastroenterology. 1983 Feb;30(1):3-5.
2
Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.慢性肝病和肝细胞癌中的乙肝e抗原和抗体。
Hepatogastroenterology. 1981 Dec;28(6):288-91.
3
Association of hepatitis B virus infection with hepatocellular carcinoma in American patients.美国患者中乙型肝炎病毒感染与肝细胞癌的关联。
普萘洛尔对马来西亚肝硬化患者的影响——药效学评估
Malays J Med Sci. 2003 Jan;10(1):65-73.
4
The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarta, Indonesia.印度尼西亚雅加达急性和慢性肝病患者中丙型肝炎病毒抗体(抗-HCV)的流行情况。
Gastroenterol Jpn. 1991 Jul;26 Suppl 3:179-83. doi: 10.1007/BF02779294.
Int J Cancer. 1980 Dec 15;26(6):711-5. doi: 10.1002/ijc.2910260603.
4
Primary liver cancer in Japan. The Liver Cancer Study Group of Japan.
Cancer. 1984 Oct 15;54(8):1747-55. doi: 10.1002/1097-0142(19841015)54:8<1747::aid-cncr2820540846>3.0.co;2-l.
5
Relationship between hepatocellular carcinoma and cirrhosis.肝细胞癌与肝硬化之间的关系。
Semin Liver Dis. 1984 May;4(2):136-46. doi: 10.1055/s-2008-1040653.
6
Hepatitis-associated antigen in hepatocellular carcinoma in Taiwan.
Taiwan Yi Xue Hui Za Zhi. 1972 Jul 28;71(7):505-8.
7
Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study.肝细胞癌中的肝炎相关抗原和抗体:一项持续研究的结果
J Natl Cancer Inst. 1972 Jun;48(6):1583-8.
8
Hepatitis-associated antigen in chronic liver disease.
Lancet. 1970 Jul 11;1(7663):100. doi: 10.1016/s0140-6736(70)92672-3.
9
Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.美国的肝细胞癌:病因学考量。乙型肝炎抗原的定位。
Gastroenterology. 1979 Feb;76(2):279-87.
10
Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.肝细胞癌与乙型肝炎病毒:因果关联的证据
Prog Med Virol. 1978;24:40-69.